Periostat
NDC Package 64682-008-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Periostat is a . Marketed by Galderma Laboratories, L.p., this product is identified by NDC 64682-008 and is authorized under FDA application NDA050783.

Identification & Billing

NDC Package Code
64682-008-03
Package Description
1000 TABLET in 1 BOTTLE
Product Code
64682-008
11-Digit Billing Format
64682000803

Clinical Specifications

Proprietary Name
Periostat
Dosage Form
-

Regulatory & Marketing

Labeler Name
Galderma Laboratories, L.p.
FDA Application #
NDA050783
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-30-1998
End Marketing Date
06-30-2010
Listing Expiration
06-30-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64682-008). Click a package code to view its specific billing and regulatory data.

64682-008-01
60 TABLET in 1 BOTTLE
64682-008-02
100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64682-008-03 identifies a specific commercial package of 1000 tablet in 1 bottle of Periostat, labeled by Galderma Laboratories, L.p.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Galderma Laboratories, L.p. on September 30, 1998. The current certification is valid through June 30, 2010.

How is this Galderma Laboratories, L.p. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64682000803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64682-008-03
11-Digit CMS (5-4-2)
64682-0008-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.